Research news

Researchers identify a mechanism that explains the recurrence of many lung infections

A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has discovered that strains of the bacterium Pseudomonas aeruginosa isolated from patients are more persistent than laboratory strains and propose a molecular mechanism to explain intracellular survival.

The study, published in the journal Virulence, finds that the class II ribonucleotide reductase enzyme (RNR) plays a key role in frequent lung infections, for example, those that occur in patients with cystic fibrosis.

Read more…

Research news

New avenues for identifying and evaluating treatments for CDKL5 deficiency disorder

Researchers from the Institute for Bioengineering of Catalonia (IBEC) have participated in a study led by Imperial College London in which the role of cyclin-dependent protein kinase 5 (CDKL5) in pain perception has been uncovered.

The defective version of the gene that produces this protein is behind CDKL5 deficiency disorder, a rare disease with no cure for which effective treatments will now be testable in mouse model, thanks to the results of this work.

Read more…

Other news

More connected than ever: IBEC reaches 16000 people and institutions on social networks

The Institute for Bioengineering of Catalonia (IBEC) has overcome the number of 16k followers on social networks, an impressive increase of 50% since May 2019. Thanks to the new Instagram account and to intensive communicative efforts of the communication unit and the research groups, IBEC is more connected than ever.

Social networks represent a global phenomenon which has radically change many aspects of communication, also in science. According to AAAS, the number of Americans going online for scientific information increased from 20% to 47% between 2006 and 2014.

Read more…

Other news

Pere Roca-Cusachs joins the European elite club in biology

Pere Roca-Cusachs, group leader at the Institute for Bioengineering of Catalonia (IBEC) and associate professor at the Faculty of Medicine of the University of Barcelona (UB), has been chosen to join the European Molecular Biology Organization (EMBO) , a prestigious network that brings together some of the most brilliant researchers in the world.

Roca-Cusachs is a pioneer in Europe in the mechanobiology field and in the study of how physical forces affect diseases such as cancer.

Read more…